Ad

MRVL – Marvel Biosciences Corp

Compliant

★☆☆☆☆

Marvel Biosciences Corp is Shariah compliant. The company’s financials pass just one standard and fail in the other four.

$2,798,412

Market cap

-

Revenue Growth

-

Analysts' Rating

Ad
N/A

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Total Analysts: 0

Company Profile

Marvel Biosciences Corp. is a Canada-based pre-clinical-stage biotechnology company. The Company is focused on the discovery of new chemical entities that inhibit the A2a adenosine receptor. The Company has developed several new chemical entities, using synthetic chemical derivatives of known drugs, that inhibit the A2a adenosine receptor with application to neurological diseases, including depression and anxiety, Alzheimer’s, attention deficit hyperactivity disorder (ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The Company is focused on the development of its lead molecule, MB-204 (Target 1b), which is in Phase I clinical trials. Its wholly owned subsidiary is Marvel Biotechnology Inc.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Ad

Responses